Skip to search.
 TSX Up 0.27% TSX Ventures Up 0.23%

Cytori Therapeutics, Inc. (CYTX)

-NasdaqGM
0.43 Down 0.01(2.02%) 2:09PM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:0.44
Open:0.44
Bid:0.43 x 600
Ask:0.44 x 200
1y Target Est:4.56
Beta:5.08
Next Earnings Date: 6-Aug-15CYTX Earnings announcement
Day's Range:0.42 - 0.46
52wk Range:0.36 - 2.21
Volume:860,522
Avg Vol (3m):2,084,830
Market Cap:65.06M
P/E (ttm):N/A
EPS (ttm):-0.57
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
CYTXDown 2.02%65.06M
ASTMDown 0.90%N/A
BAXUp 2.91%21.53B
OSIRUp 1.63%730.44M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):6.50
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.29
Quarterly EPS Est (Jun-15) :-0.03
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cytori Therapeutics, Inc., a biotechnology company, develops cell therapeutics for specific diseases and medical conditions. The company primarily provides Cytori Cell Therapy consisting of a heterogeneous population of specialized cells, includin... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback